PEAR1 polymorphisms as a prognostic factor in hemostasis and cardiovascular diseases
This study aims to evaluate the prognosis and drug treatment of the PEAR1 gene in CVDs patients.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Genetics | Heart | Hematology | Study | Thrombosis